ORC: A Potential Drug Target Or Biomarker (P15572)

Target Name: Origin recognition complex

NCBI ID: P15572

Other Name(s): ORC

ORC: A Potential Drug Target Or Biomarker

Origin recognition complex (ORC) is a protein that plays a crucial role in the immune system. It is a family of transmembrane proteins that belong to the superfamily of SNAP/NIPP family. ORC plays an important role in cellular immune responses and participates in the antigen presentation pathway by recognizing MHC molecules on antigen-presenting cells (APCs). In certain diseases, ORC may be a potential drug target or biomarker.

ORC is an intracellular protein distributed inside the cell membrane. ORC consists of two major domains: N-terminal 伪-helix and C-terminal 尾-coil. These domains form a highly conserved secondary structure and are an important component of ORC. The interaction between the 伪-helix and 尾-coil structures in ORC makes ORC highly stable.

ORC is involved in many key steps in the antigen presentation pathway. When APC is stimulated by an antigen, the 伪-helix in ORC can interact with the 伪-helix in the MHC molecule, thereby exposing the ORC to a site that can bind to the antigen-specific receptor. Subsequently, the 尾-coil in ORC can play a key role in the interaction between antigen-presenting cells (APCs) and antigen-specific receptors.

ORC not only plays a role in cellular immune responses but also in cellular metabolism and signal transduction. Studies have shown that ORC may be involved in intracellular energy metabolism and intracellular signaling.

Since ORC plays an important role in both cellular immune responses and metabolic processes, it is a potential drug target or biomarker. Researchers have developed many ORC-related drugs, including antibodies, vaccines, and drug molecules. These drugs can modulate the interaction between APC and antigen-specific receptors, thereby inhibiting tumor growth and improving immune responses.

However, it is unclear whether ORC is an ideal drug target or biomarker. Some studies suggest that ORC may be involved in many steps in tumorigenesis and progression. For example, ORC expression levels are positively correlated with prognosis in breast and colon cancers. Furthermore, ORC expression levels correlate with the progression and invasiveness of lung and ovarian cancers.

Therefore, ORC is a drug target or biomarker worthy of further study. Researchers should continue to study the biological functions of ORC and explore whether ORC is a potential drug target or biomarker.

Protein Name: Origin Recognition Complex

More Common Targets